




Fifty-one patients with a mean age of 31.2 years underwent aortic valve 
replacement with glutaraldehyde-treated autologous pericardium. Pure 
aortic regurgitation was present in 28 (54.9%), stenosis in 9, and mixed 
disease in 14. Simultaneous mitral valve repair was done in 17 patients and 
replacement in 1. There were no hospital and two late deaths. Three 
patients required reoperation because of failure of the pericardial valve as 
a result of infective endocarditis in two (5 and 31 months after operation) 
and commissural tear at 8 months in another. One patient underwent 
reoperation at 24 months because of failure of the mitral valve repair. The 
pericardial aortic valve, which had 2+ regurgitation since the first opera- 
tion, was also replaced. Macroscopic and microscopic examination findings 
in the excised pericardium were excellent. No thromboembolic events have 
been detected and no patient received anticoagulation therapy except one 
after mitral valve reoperation and replacement with a mechanical valve. 
The actuarial survival was 84.53% -- 12.29% at 60 months, freedom from 
failure of the aortic reconstruction 83.83% - 8.59%, and freedom from any 
event 72.59% _-4- 12.79%. Doppler echocardiographic study at most recent 
follow-up showed a mean gradient of 12.56 +- 8.10 mm Hg and mean 
regurgitation on a scale from 0 to 4+ of 0.80 -- 0.66. Although the 
maximum follow-up is only 5 years, the results obtained so far encourage us 
to continue replacing the aortic valve with stentless autologous pericar- 
dium. (J THORAC CARDIOVASC SURG 1995;110:511-6) 
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A uto1ogous pericardium, because of its ready availability, ease of handling, and low cost, has 
been used regularly since the early days of cardiac 
surgery. However, because of intermittent reports 
of its tendency to retract or become aneurysmal, 
the general opinion has been negative. Our posi- 
tive experience with triple aortic cusp extension 
with bovine pericardium 1 and the description by 
Chachques and associates a of a rapid method to 
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stabilize pericardium encouraged us to initiate a 
series of total aortic valve replacement with glutar- 
aldehyde-treated autologous pericardium. This pa- 
per reports our total experience in 51 patients. 
Patients and methods 
Beginning in April 1989, 51 consecutive patients under- 
went aortic valve replacement with autologous pericar- 
dium. Patient selection was based on the preferences of 
the individual surgeon and does not represent a truly 
general population because initially only young patients 
with expected problems of permanent anticoagulation 
were selected. With experience and given the positive 
findings in terms of low transvalvular g adients in patients 
with a small aortic anulus, the indications were expanded 
to include older patients with calcific stenosis. 
The preoperative patient data are shown in Table I. The 
mean age was 31.2 years with a range of 14 to 68 and a 
median of 26 years. Fifteen patients were female and 36 
male. The cause of disease was rheumatic in 43 (84.3%), 
degenerative in 5 (9.8%), congenital in 2, and infective in 
1. The mean preoperative New York Heart Association 
(NYHA) functional class was 2.57. Forty-seven (93%) 
patients were in sinus rhythm and four in atrial fibrillation. 
The diagnosis was established with transthoracic color 
Doppler echocardiography in all cases. Coronary angiog- 
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Table I. Preoperative data in 51 patients with aortic valve replacement with autologous pericardium 
Associated mitral 
valve disease 
Mean Sinus Mean Mean 
age Rheumatic rhythm NYHA Mean AR (on scale gradient Percent having 
Diagnosis n (%) (yr) cause (%) (%) class from 1-4+) (ram Hg) n repair 
AR 28 (54.9) 24 27 (96.4) 26 (92.9) 2.43 3.52 -+ 0.54 11.12 - 4.44 11 100 
AS 9 (17.6) 53.2 5 (55.0) 7 (77.8) 2.89 0.75 _+ 0.38 53 --- 10.57 2 100 
Mixed 14 (27.4) 31.5 11 (78.6) 14 (100) 2.64 2.69 _+ 0.72 39.42 +_ 11.45 5 80 
Total 51 (100) 31.2 43 (84.3) 47 (93) 2.57 2.78 _+ 1.15 29.48 _+ 20.80 18 94.4 
AR, Aortic valve regurgitation; AS, aortic valve stenosis; Mixed, aortic valve stenosis and regurgitation. 
raphy was done only in male patients older than 45 years 
and female patients older than 50 years unless the clinical 
data suggested that it was necessary. No patient in this 
series had coronary artery disease. Twenty-eight (54.9%) 
patients had pure aortic regurgitation, 9 aortic stenosis, 
and 14 mixed lesions. Mitral valve disease was present in 
18 patients and tricuspid valve disease in 1. All patients 
underwent intraoperative transesophageal chocardiogra- 
phy (TEE). Specific and essential data searched for were 
the diameter of the aortic anulus, as measured from 
opposing cusp insertion points in the long axis view, and 
the presence of a trileaflet valve. Calcification, even of the 
anulus was no contraindication. 
Myocardial protection was achieved, initially, with cold 
crystalloid potassium cardioplegia nd, since 1991, with 
antegrade and retrograde cold blood cardioplegia. The 
heart was vented in every case. If there was involvement of 
other valves, they were exposed first and, in the case of the 
mitral valve, treated appropriately first. In general, mitral 
valve replacement was considered a contraindication to
aortic valve reconstruction. 
The whole surgical technique of valve reconstruction 
was an attempt at reproducing as closely as possible the 
normal aortic leaflets tailored to the individual patient. In 
accordance with the work of Swanson and Clark, 3 who 
provided the measures of the aortic valve relative to the 
aortic anulus, plastic containers with three consecutive 
bulges of different sizes were made. These bulges repro- 
duced the three valve leaflets with measures correspond- 
ing to the different aortic valve diameters. After the 
midline sternotomy was completed, a rectangular strip of 
pericardium was resected with a total length of about 1 cm 
more than three times the TEE-measured aortic anulus 
diameter and a width of one diameter. After it was 
cleaned, the pericardium was placed in the appropriate 
container filled with 0.5% buffered glutaraldehyde. The 
pericardial strip was held in position, over the three 
bulges, with a perforated plastic sheath of the same 
dimension as the negative of the bulges. After fixation for 
10 minutes the pericardium was rinsed for another 10 
minutes and trimmed own. The pericardium was sutured 
to the aortic valve remnant or to the anulus with a single 
4-0 polypropylene running suture following a technique 
described in detail elsewhere. 4 Basically, suturing started 
at the midpoint of each sinus and was stopped against he 
suture of the next cusp. The portion of the pericardial 
strip between leaflets was sutured as a new commissure to 
the aortic wall. The two extremities of the strip were 
similarly sutured to the aortic wall as the third new 
commissure (Fig. 1). After the patient was weaned from 
bypass TEE was done in all cases. 
All patients were followed up in a dedicated valve clinic 
by two physicians 8 weeks and 6 months after operation 
and at yearly intervals thereafter. If a patient failed to 
attend the clinic he or she was contacted by a social 
worker who had visited them during their hospital stay. 
The preoperative, surgical, postoperative, and follow-up 
data were entered into a software program (PATS, Den- 
drite, Portland, Ore.). All events were noted according to 
the guidelines issued by The American Association for 
Thoracic Surgery and the Society of Thoracic Surgeons. 5 
Statistical significance of the echocardiographic data was 
analyzed with the Student's t test. 
Results 
Between April 1989 and June 1994, 51 patients 
underwent aortic valve replacement with glutaralde- 
hyde-treated autologous pericardium. Eighteen pa- 
tients had simultaneous mitral valve operation with 
17 repairs and 1 replacement with a bioprosthesis. 
The mean cardiopulmonary bypass time for the 
whole group of patients was 131.8 minutes and the 
crossclamp time 96.9 minutes. For those patients 
with an isolated aortic valve operation the mean 
bypass time was 122.8 minutes and the mean cross- 
clamp time 87.9 minutes. 
There were no hospital deaths although in four 
patients not included in this series the result of the 
reconstruction was not considered satisfactory and a 
replacement with a prosthesis was undertaken with- 
out mortality. Three patients were lost to follow-up 
(94.1% complete) with a maximum of 61 months 
and mean of 21.2 months. The total follow-up was 
88.97 patient-years. There were no thromboembol ic 
events. Two late deaths (3.9%) have occurred: one 
patient died in a car accident and the second died in 
another hospital apparently of left ventricular fail- 
ure with a competent aortic valve. There were three 
reoperations, without mortality, which were neces- 
sary because of failure of the reconstruction (5.8%). 
The causes were endocarditis in two patients (5 and 
31 months after operation) and tear of a cusp near 
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Fig. 1. Surgical technique for aortic valve replacement with autologous pericardium. Left inset, Tanning of 
autologous pericardium. Right inset, Anchoring sutures. 
one commissure in the third patient 8 months after 
operation. One patient required reoperation be- 
cause of failure of the mitral valve repair 24 months 
after the initial operation. The aortic valve in this 
patient, which had a 2+ regurgitation score since 
the first operation, was replaced because the dys- 
functioning mitral valve was replaced with a me- 
chanical valve and the possibility of a third opera- 
tion was rejected by the patient. The autologous 
pericardium was perfectly healed, thin, and mobile 
without any thrombus or macroscopic fibrin deposi- 
tion or calcification (Fig. 2). Histologic examination 
showed perfect conservation of the collagen fibers, 
no cell infiltration, and patchy neointima. At the 
base of the c, usps on the arterial aspect a thin fibrous 
and cellular layer could be observed that extended 
for a few mJ[llimeters (Fig. 3). 
The mean postoperative NYHA functional class at 
most recent visit was 1.22. The actuarial survival was 
84.53% _+ 12.29% at 60 months. Freedom from failure 
of the reconstruction was 83.83% _+ 8.59% and the 
actuarial freedom from any event was 72.59% __ 
12.79% again at 60 months after operation (Fig. 4). 
The echocardiographic data of the patients before 
operation, at discharge from the hospital, and at 
most recent follow-up are shown in Table II. Note- 
worthy findings were the range of aortic anulus 
diameters measured intraoperatively, which varied 
from 17 to 31 mm, and the significant difference in 
degree of aortic regurgitation between the preoper- 
ative and postoperative measurements. There was 
no significant change between the early and late 
postoperative grade of regurgitation and transvalvu- 
lar gradients, which advocates the stability of the 
technique at medium range. The mean postopera- 
tive gradients were low, which is particularly impor- 
tant in the stenotic lesions. 
Discussion 
Aortic valve cusp extension with pericardium has 
a long history dating to 1963 when Ross 6 reported 
one case of aortic insufficiency treated with single 
cusp enlargement with autologous fresh pericar- 
dium. In 1964 Bj6rk and Hultquist 7 decribed the 
pathologic findings of two cases of cusp extension 
with presumably autologous fresh pericardium: one 
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Fig. 2. Macroscopic appearance of autologous pericardium explanted 2 years after implantation. Reop- 
eration was necessary because of mitral valve dysfunction. 
Fig. 3. Cross section f autologous pericardium 2 years after implantation. Lower aspect corresponds to 
aortic surface (Masson's trichrome stain; original magnification ×50). 
patient died 5 months after operation with a thick- 
ened and calcified pericardium and the other at 
reoperation for severe valvular insufficiency present 
since the first operation done 31/2 months previously. 
Edwards  in 1969 described a surgical technique for 
total valve replacement with autogenous tissue stud- 
ied in vitro and applied with pericardium in two 
patients: one of the patients died 1 week later with 
a competent valve at autopsy. Bahnson and associ- 
ates 9 in 1970 reported two cases of single leaflet 
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Fig. 4. Actuarial survival and freedom from reoperation curves in 51 patients with autologous pericardium 
aortic valve replacement. 
Table II. Color Doppler echocardiographic data in 51 patients with autologous pericardium aortic valve 
replacement 
AR AS Mixed Total 
Anulus diameter (mm) 27.33 + 2.09 20.20 -+ 2.59 21.88 _+ 4.05 24.52 _+ 4.10 
(range) (24-31) (18-23) (17-30) (17-31) 
Preoperative findings 
AR 3.52 _+ 0.54* 0.75 -+ 0.38 2.69 _+ 0.72* 2.78 _+ 1.15" 
Gradient (mm Hg) 11.12 _+ 4.44 53 -+ 10.57" 39.42 _+ 11.45" 29.48 -- 20.80* 
Discharge findings 
AR 0.69 ~ 0.53 0.69 -+ 0.46 0.75 -+ 0.40 0.69 -+ 0.48 
Gradient (mm Hg) 9.18 _+ 3.65 16.43 -+ 11.16 8.83 _+ 2.62 10.21 _+ 5.87 
Most recent follow-up 
AR 0.82 -+ 0.78 0.75 -+ 0.38 0.81 -+ 0.60 0.80 -+ 0.66 
Gradient (ram Hg) 11.94 _+ 7.07 16.57 -+ 13.72 10.91 + 3.73 12.56 _+ 8.10 
Mean grade of aortic regurgitation as determined on scale from 0 to 4+. Gradient is the Doppler mean transvalvular g adient in millimeters of mercury.,,4R, 
Aortic regurgitation; AS, aortic stenosis; Mixed, aortic stenosis and regurgitation. 
*p < 0.001 significance v rsus discharge and most recent follow-up. 
replacement and three cases of triple leaflet exten- 
sions with autologous pericardium. Although all 
patients had residual regurgitation, three of them 
were doing well 11/2, 41/2, and 41/2 years after opera- 
tion. These isolated and inconclusive attempts re- 
mained practically forgotten and displaced by the 
reliability of the new prostheses. The availability of 
glutaraldehyde-treated xenogeneic pericardium en- 
couraged Yacoub and associates 1°to use calf peri- 
cardium treated in 0.2% glutaraldehyde for 7 days in 
45 patients with an actuarial survival of 89% at 7 
years. Batista and associates 11 in 1986 reported 
excellent results with a single strip of glutaralde- 
hyde-treated bovine pericardium in 60 consecutive 
patients. The same group later reported no calcifi- 
cations in 216 patients followed up for up to 6 
years. 12 Because of the youth and difficulty of per- 
manent anticoagulation i  our patients, it was de- 
cided to follow the technique already described by 
Batista and associates 11in which as little as possible 
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of the cusp free edge was resected and a large strip 
of commercially available glutaraldhyde-treated bo- 
vine pericardium was sutured to the three cusps to- 
gether with the construction ofvery high new commis- 
sures. This technique was applied beginning in July 
1988 to 27 patients with excellent results to date in all 
patients, except in one who at 58 months was seen with 
calcification of one cusp. The intraoperative observa- 
tion in four cases of severe electrocardiographic isch- 
emic changes that were transient in three but that 
necessitated valve replacement in the fourth alerted us 
to a possible pitfall of this technique. The report of 
four early deaths caused by "myocardial dysfunction" 
in the series of Batista 11 in very young patients and the 
direct visual observation of the reconstructed valve 
through a cystoscope, a3 which showed bending of the 
free edge of the pericardium toward the sinuses of 
Valsalva, confirmed the suspicion. A new surgical 
technique for the total replacement of the aortic valve 
was developed in the experimental l boratory in which 
autologous pericardium was shaped into three cusps 
during the glutaraldehyde fixation. 
Two main questions must be addressed when the 
use of this approach is being considered. The first is 
the need for a standard surgical technique that ensures 
a correct, reproducible, and safe result in terms of 
immediate competence and low transvalvular gradi- 
ents. The second is the long-term durability of the 
selected material. The absence of hospital mortality 
and transient or permanent ischemic hanges and the 
findings of echocardiographic valve competence and 
nonsignificant gradients are indicators of a reliable 
surgical technique. In terms of durability, the maxi- 
mum follow-up of 61 months is still too short. Two 
patients had to undergo reoperation because of endo- 
carditis. This nearly 5% prevalence is a cause of 
concern particularly when the main problem in the 
experience of Senning 14 with fresh autologous fascia 
lata was infective ndocarditis present in 14% of his 
cases. In our experience, the different anatomic local- 
ization and the pretreatment of the pericardium with 
glutaraldehyde should reduce this potential danger. 
One patient had to undergo reoperation because of 
rupture of the left coronary leaflet next to the right and 
left commissure. This area corresponds to where the 
two ends of the strip of pericardium ust be joined 
when the new commissure is fashioned and this area 
might have been either damaged or insufficiently sup- 
ported. The excellent macroscopic and microscopic 
findings in the explanted pericardium 2 years after 
implantation are encouraging. It is believed that being 
stemless and nonantigenic this tissue should perform 
at least better than the standard bioprosthesis. 
The immediate and late echocardiographic data 
are also encouraging not only in terms of valve 
competence but also as regards gradients, even in 
the presence of a small aortic anulus. This last 
finding has allowed an expansion of the indications 
for this procedure to those older patients with small 
stenotic and calcified aortic valves. 
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